|
US4093557A
(en)
|
1976-09-16 |
1978-06-06 |
Hercules Incorporated |
Process for inhibiting corrosion of metals in aqueous systems
|
|
AR240698A1
(es)
|
1985-01-19 |
1990-09-28 |
Takeda Chemical Industries Ltd |
Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales
|
|
ATE186724T1
(de)
|
1987-09-04 |
1999-12-15 |
Beecham Group Plc |
Substituierte thiazolidindionderivate
|
|
US4783495A
(en)
|
1987-11-20 |
1988-11-08 |
Ciba-Geigy Corporation |
(Hydroxyphenyl) silane stabilizers
|
|
US4835202A
(en)
|
1987-11-20 |
1989-05-30 |
Ciba-Geigy Corporation |
(Hydroxyphenyl) phosphine stabilized compositions
|
|
JPH02121941A
(ja)
|
1988-10-28 |
1990-05-09 |
Teijin Chem Ltd |
ハロゲン化トリスフェニル誘導体および難燃性熱可塑性樹脂組成物
|
|
IE61928B1
(en)
|
1988-11-29 |
1994-11-30 |
Boots Co Plc |
Treatment of obesity
|
|
US5399363A
(en)
|
1991-01-25 |
1995-03-21 |
Eastman Kodak Company |
Surface modified anticancer nanoparticles
|
|
JPH04268328A
(ja)
|
1991-02-22 |
1992-09-24 |
Idemitsu Petrochem Co Ltd |
分岐ポリカーボネート
|
|
JPH04328555A
(ja)
|
1991-04-26 |
1992-11-17 |
Fuji Photo Film Co Ltd |
ポジ型フオトレジスト組成物
|
|
US5198531A
(en)
|
1991-06-14 |
1993-03-30 |
Research Diagnostic Antibodies |
Polymeric resin for peptide synthesis
|
|
EP0567626B1
(en)
|
1991-11-19 |
2001-09-19 |
Amylin Pharmaceuticals, Inc. |
Amylin agonist peptides and uses therefor
|
|
WO1993015063A1
(en)
|
1992-02-03 |
1993-08-05 |
Hoechst Celanese Corporation |
Uv light stabilizing, antioxidant and colorant compounds
|
|
FR2692575B1
(fr)
|
1992-06-23 |
1995-06-30 |
Sanofi Elf |
Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
|
|
GB9218830D0
(en)
|
1992-09-05 |
1992-10-21 |
Smithkline Beecham Plc |
Novel compounds
|
|
JP2845743B2
(ja)
|
1992-12-28 |
1999-01-13 |
三菱化学株式会社 |
新規なナフタレン誘導体
|
|
US5543158A
(en)
|
1993-07-23 |
1996-08-06 |
Massachusetts Institute Of Technology |
Biodegradable injectable nanoparticles
|
|
JP3026707B2
(ja)
|
1993-10-05 |
2000-03-27 |
出光石油化学株式会社 |
分岐状ポリカーボネートの製造方法
|
|
US5583016A
(en)
|
1994-07-07 |
1996-12-10 |
Geron Corporation |
Mammalian telomerase
|
|
US6028103A
(en)
|
1994-09-16 |
2000-02-22 |
Children's Medical Center Corporation |
Triaryl methane compounds and analogues thereof useful for the treatment or prevention of sickle cell disease or diseases characterized by abnormal cell proliferation
|
|
DE4439947A1
(de)
|
1994-11-09 |
1996-05-15 |
Boehringer Mannheim Gmbh |
2,2-Dichloralkancarbonsäuren, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
|
|
US5571825A
(en)
|
1995-03-31 |
1996-11-05 |
Warner-Lambert Company |
Method of selectively inhibiting prostaglandin G/H synthase-2
|
|
IE80468B1
(en)
|
1995-04-04 |
1998-07-29 |
Elan Corp Plc |
Controlled release biodegradable nanoparticles containing insulin
|
|
CZ293016B6
(cs)
|
1995-06-01 |
2004-01-14 |
Sankyo Company Limited |
Benzimidazolové deriváty a farmaceutické prostředky s jejich obsahem
|
|
US6297269B1
(en)
|
1995-06-06 |
2001-10-02 |
Pfizer Inc. |
Substituted n-(indole-2-carbonyl-) amides and derivatives as glycogen phosphorylase inhibitors
|
|
GB9604242D0
(en)
|
1996-02-28 |
1996-05-01 |
Glaxo Wellcome Inc |
Chemical compounds
|
|
US5889038A
(en)
|
1996-03-20 |
1999-03-30 |
Children's Hospital |
Methods and products for treating diarrhea and scours: use of clotrimazole and related aromatic compounds
|
|
ATE314060T1
(de)
|
1996-03-20 |
2006-01-15 |
Harvard College |
Triarylmethanverbindungen zur behandlung von krebs, aktinischer keratose und kaposisarkom
|
|
US6191165B1
(en)
|
1996-05-31 |
2001-02-20 |
Allelix Neuroscience Inc. |
Pharmaceutical for treatment of neurological and neuropsychiatric disorders
|
|
AR008789A1
(es)
|
1996-07-31 |
2000-02-23 |
Bayer Corp |
Piridinas y bifenilos substituidos
|
|
DE122009000079I2
(de)
|
1996-08-30 |
2011-06-16 |
Novo Nordisk As Novo Alle |
Glp-1 derivate
|
|
JP4128247B2
(ja)
|
1996-11-01 |
2008-07-30 |
株式会社リコー |
フェノール系化合物及び電子写真感光体
|
|
JPH10153884A
(ja)
|
1996-11-25 |
1998-06-09 |
Minolta Co Ltd |
静電潜像現像用トナー
|
|
WO1998035033A1
(en)
|
1997-02-05 |
1998-08-13 |
1149336 Ontario Inc. |
Polynucleotides encoding proexendin, and methods and uses thereof
|
|
DE19711617A1
(de)
*
|
1997-03-20 |
1998-09-24 |
Boehringer Mannheim Gmbh |
Neue Thiazolidindione, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
|
|
DE19823831A1
(de)
|
1998-05-28 |
1999-12-02 |
Probiodrug Ges Fuer Arzneim |
Neue pharmazeutische Verwendung von Isoleucyl Thiazolidid und seinen Salzen
|
|
JP3728205B2
(ja)
|
1998-07-02 |
2005-12-21 |
マイクロリス・コーポレイション |
固体表面を液状配合物で被覆する方法
|
|
FR2783246B1
(fr)
|
1998-09-11 |
2000-11-17 |
Aventis Pharma Sa |
Derives d'azetidine, leur preparation et les medicaments les contenant
|
|
DE19844547C2
(de)
|
1998-09-29 |
2002-11-07 |
Aventis Pharma Gmbh |
Polycyclische Dihydrothiazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
|
KR100353014B1
(ko)
|
1998-11-11 |
2002-09-18 |
동아제약 주식회사 |
발기부전 치료에 효과를 갖는 피라졸로피리미디논 화합물
|
|
CO5150173A1
(es)
|
1998-12-10 |
2002-04-29 |
Novartis Ag |
Compuestos n-(glicilo sustituido)-2-cianopirrolidinas inhibidores de peptidasa de dipeptidilo-iv (dpp-iv) los cuales son efectivos en el tratamiento de condiciones mediadas por la inhibicion de dpp-iv
|
|
US6380378B1
(en)
|
1998-12-24 |
2002-04-30 |
Toagosei Company, Ltd. |
Nucleotide compound, nucleotide block oligonucleotide, and method for producing them
|
|
GB9900416D0
(en)
|
1999-01-08 |
1999-02-24 |
Alizyme Therapeutics Ltd |
Inhibitors
|
|
FR2789079B3
(fr)
|
1999-02-01 |
2001-03-02 |
Sanofi Synthelabo |
Derive d'acide pyrazolecarboxylique, sa preparation, les compositions pharmaceutiques en contenant
|
|
US6417208B1
(en)
|
1999-02-05 |
2002-07-09 |
Albert Einstein College Of Medicine Of Yeshiva University |
Method of identification of inhibitors of PDE1C
|
|
JP4195145B2
(ja)
|
1999-04-01 |
2008-12-10 |
出光興産株式会社 |
ポリカーボネートの製造方法
|
|
US6262118B1
(en)
|
1999-06-04 |
2001-07-17 |
Metabolex, Inc. |
Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemia
|
|
EP1076066A1
(en)
|
1999-07-12 |
2001-02-14 |
Zealand Pharmaceuticals A/S |
Peptides for lowering blood glucose levels
|
|
CA2647796A1
(en)
|
1999-07-28 |
2001-02-08 |
The Trustees Of The University Of Pennsylvania |
Method of inhibiting osteoclast activity
|
|
CA2383466C
(en)
|
1999-09-16 |
2009-08-25 |
Tanabe Seiyaku Co., Ltd. |
Aromatic nitrogen-containing 6-membered cyclic compounds
|
|
TWI302149B
(en)
|
1999-09-22 |
2008-10-21 |
Bristol Myers Squibb Co |
Substituted acid derivatives useful as antiodiabetic and antiobesity agents and method
|
|
AU7961800A
(en)
|
1999-10-28 |
2001-05-08 |
Kyowa Hakko Kogyo Co. Ltd. |
Thiazolidinedione derivatives
|
|
SE9904413D0
(sv)
|
1999-12-03 |
1999-12-03 |
Astra Ab |
Comminuted form
|
|
CN1740182A
(zh)
|
1999-12-22 |
2006-03-01 |
症变治疗公司 |
新的双氨基化膦酸酯前药
|
|
US6803375B1
(en)
|
2000-01-06 |
2004-10-12 |
The Regents Of The University Of California |
Non-peptide inhibition of T-lymphocyte activation and therapies related thereto
|
|
JP4187934B2
(ja)
|
2000-02-18 |
2008-11-26 |
富士フイルム株式会社 |
ポジ型レジスト組成物
|
|
US6395767B2
(en)
|
2000-03-10 |
2002-05-28 |
Bristol-Myers Squibb Company |
Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method
|
|
HUP0300725A3
(en)
|
2000-08-11 |
2005-11-28 |
Pfizer |
Treatment of the insulin resistance syndrome with selective cgmp pde5 inhibitors
|
|
ATE512964T1
(de)
|
2000-10-12 |
2011-07-15 |
Cancer Rec Tech Ltd |
N8,n13-disubstituierte chinoä4,3,2,klüacridinium salze als arzneimittel
|
|
GB0031103D0
(en)
|
2000-12-20 |
2001-01-31 |
Glaxo Group Ltd |
Chemical compounds
|
|
US20040132830A1
(en)
|
2001-01-19 |
2004-07-08 |
Finer Jeffrey T |
Triphenylmethane kinesin inhibitors
|
|
EP1355651A2
(en)
|
2001-02-02 |
2003-10-29 |
Pfizer Limited |
Treatment of diabetes mellitus using vardenafil
|
|
CN1543451A
(zh)
|
2001-06-07 |
2004-11-03 |
|
过氧化物酶体增生剂激活的受体的调节剂
|
|
JP3909056B2
(ja)
|
2001-06-27 |
2007-04-25 |
スミスクライン ビーチャム コーポレーション |
ジペプチジルペプチダーゼ阻害剤としてのフルオロピロリジン類
|
|
UA74912C2
(en)
|
2001-07-06 |
2006-02-15 |
Merck & Co Inc |
Beta-aminotetrahydroimidazo-(1,2-a)-pyrazines and tetratriazolo-(4,3-a)-pyrazines as inhibitors of dipeptylpeptidase for the treatment or prevention of diabetes
|
|
US6766960B2
(en)
|
2001-10-17 |
2004-07-27 |
Kilopass Technologies, Inc. |
Smart card having memory using a breakdown phenomena in an ultra-thin dielectric
|
|
US7045523B2
(en)
|
2001-10-18 |
2006-05-16 |
Novartis Ag |
Combination comprising N-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2-pyrimidine-amine and telomerase inhibitor
|
|
KR20040053210A
(ko)
|
2001-11-02 |
2004-06-23 |
화이자 프로덕츠 인크. |
Ｐｄｅ9 억제제를 사용한 인슐린 저항 증후군 및 2형당뇨병의 치료
|
|
WO2003059934A2
(en)
|
2001-12-21 |
2003-07-24 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
|
WO2003066814A2
(en)
|
2002-02-04 |
2003-08-14 |
Ceremedix, Inc. |
Peptide-dependent upregulation of telomerase expression
|
|
AU2003220342B2
(en)
|
2002-03-14 |
2007-06-07 |
Bayer Pharmaceuticals Corporation |
Methods of treating diabetes using PDE 11A inhibitors
|
|
CA2519357A1
(en)
|
2003-03-17 |
2004-09-30 |
Pfizer Products Inc. |
Treatment of type 1 diabetes with pde5 inhibitors
|
|
US20040220186A1
(en)
|
2003-04-30 |
2004-11-04 |
Pfizer Inc. |
PDE9 inhibitors for treating type 2 diabetes,metabolic syndrome, and cardiovascular disease
|
|
JP4517723B2
(ja)
|
2003-05-22 |
2010-08-04 |
住友ベークライト株式会社 |
ナフトキノンジアジドスルホン酸エステル、それを用いたポジ型感光性樹脂組成物、半導体装置及び表示素子
|
|
AP2280A
(en)
|
2003-06-23 |
2011-10-31 |
Geron Corp |
Compositions and methods for increasing telomeraseactivity.
|
|
MXPA05013553A
(es)
|
2003-06-30 |
2006-03-09 |
Altana Pharma Ag |
Pirrolodihidroisoquinolinas como inhibidores de pde10.
|
|
EP1651251A4
(en)
|
2003-07-31 |
2008-06-18 |
Bayer Pharmaceuticals Corp |
METHOD FOR THE TREATMENT OF DIABETES AND RELATED DISEASES USING PDE 10A INHIBITORS
|
|
US20050049208A1
(en)
*
|
2003-09-03 |
2005-03-03 |
Kaufmann Doug A. |
Method of treating and method of preventing diabetes
|
|
CN102079743B
(zh)
|
2004-03-15 |
2020-08-25 |
武田药品工业株式会社 |
二肽基肽酶抑制剂
|
|
BRPI0511854A
(pt)
|
2004-06-07 |
2008-01-15 |
Pfizer Prod Inc |
inibição de fosfodiestearase 10 como tratamento para condições relacionados com a obesidade e relacionadas a sìndrome metabólica
|
|
WO2006007864A1
(en)
|
2004-07-17 |
2006-01-26 |
Max Planck Geselllschaft Zur Förderung Der Wissenschaft |
Treating neurodegenerative conditions
|
|
JP4929569B2
(ja)
|
2004-08-20 |
2012-05-09 |
東レ株式会社 |
高分子電解質材、ならびにそれを用いた高分子電解質膜、膜電極複合体および高分子電解質型燃料電池
|
|
EP2305246B1
(en)
|
2005-01-31 |
2015-08-26 |
The Trustees of the University of Pennsylvania |
Tumor necrosis factor inhibitors
|
|
WO2006084031A1
(en)
|
2005-02-01 |
2006-08-10 |
Icagen, Inc. |
Imines as ion channel modulators
|
|
JP5211438B2
(ja)
|
2005-06-09 |
2013-06-12 |
東レ株式会社 |
樹脂組成物およびそれを用いた表示装置
|
|
PT2152663E
(pt)
*
|
2007-06-04 |
2014-06-03 |
Univ Ben Gurion |
Compostos de triarilo e composições que compreendem os mesmos
|